SCHEMBL633120

SCHEMBL633120

CC1CCCC(OC=O)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.32
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12166897 1.00 MCHR1 (0.32) MCHR1RAB9A
SCHEMBL12438852 1.00 MCHR1 (0.32) MCHR1RAB9A
SCHEMBL1767352 0.86
SCHEMBL4288754 0.83
SCHEMBL14480073 0.80 MCHR1 (0.33) MCHR1
SCHEMBL28314906 0.79
SCHEMBL5612535 0.78 MCHR1 (0.32) MCHR1
SCHEMBL4745532 0.78 DPP4 (0.36)
SCHEMBL96545 0.78
SCHEMBL11210270 0.78 ADH1A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842744-B2 excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound ADEKA CORPORATION (JP) 2010-11-30 US claimed
US-20090258976-A1 excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound NEGISHI YOSHINORI 2009-10-15 US claimed
US-7553892-B2 excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound ADEKA CORPORATION (JP) 2009-06-30 US claimed
CN-118338782-A Biocidal compositions 巴斯夫欧洲公司 2024-07-12 CN disclosed
WO-2024128000-A1 ISOPOLYOXOTUNGSTATE SALT COMPOUND, SOLVATE THEREOF OR MIXTURE OF SAID COMPOUND AND SOLVATE, AND METHOD FOR PRODUCING SAID COMPOUND, SOLVATE OR MIXTURE 東京応化工業株式会社 2024-06-20 WO disclosed
CN-117143082-A Azabicyclo [3.1.0] hexane derivatives useful as 3C-like protease inhibitors 广州国家实验室 2023-12-01 CN disclosed
EP-3081552-B1 PEST CONTROL AGENT CONTAINING AN AMIDE DERIVATIVE AND USE OF THE PEST CONTROL AGENT MITSUI CHEMICALS AGRO INC (JP) 2021-03-03 EP disclosed
EP-3440077-B1 PROCESS FOR PRODUCING LAMIVUDINE AND EMTRICITABINE UNIV NELSON MANDELA METROPOLITAN (ZA) 2020-07-01 EP disclosed
US-10582708-B2 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative MITSUI CHEMICALS AGRO, INC. (JP) 2020-03-10 US disclosed
EP-2325165-B1 AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE AND PEST CONTROLLING METHOD MITSUI CHEMICALS AGRO INC (JP) 2020-02-19 EP disclosed
US-20170367329-A1 AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND USE OF THE AMIDE DERIVATIVE MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) 2017-12-28 US disclosed
EP-0276131-B1 NON-NATURAL DEMETHYLAVERMECTINS AND PROCESS THEREFOR PFIZER INC. (US) 1993-04-07 EP disclosed
EP-0316124-B1 ETHYLATED AVERMECTINS PFIZER INC. (US) 1993-04-07 EP disclosed
US-5089480-A ANTIPARASITIC AGENTS PFIZER INC. (US) 1992-02-18 US disclosed
US-5077278-A Parasiticides PFIZER INC. (US) 1991-12-31 US disclosed
EP-0316124-A2 Ethylated avermectins PFIZER INC. (US) 1989-05-17 EP disclosed
EP-0313297-A2 Process for production of avermectin aglycones and cultures therefor PFIZER INC. (US) 1989-04-26 EP disclosed
EP-0284176-A2 Process for production of avermectins and cultures therefor PFIZER INC. (US) 1988-09-28 EP disclosed
EP-0276103-A2 Process for production of B avermectins and cultures therefor PFIZER INC. (US) 1988-07-27 EP disclosed
EP-0276131-A2 Non-natural demethylavermectins and process therefor PFIZER INC. (US) 1988-07-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10582708-B2 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative H1-2, H1-4, H1-0 MCHR1 3046/4885RAB9A 2152/4885
US-20170367329-A1 AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND USE OF THE AMIDE DERIVATIVE H1-2, H1-4, H1-0 MCHR1 3046/4885RAB9A 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.